Learn how to identify chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation using blood eosinophil (EOS) levels, understand the associated risks, and recognize factors that may influence EOS counts.
This is the full presentation of the March 2025 ADVENT cross-dermatology symposium, hosted in Orlando, Florida, presenting the latest information around type 2 inflammation and its association with atopic dermatitis (AD), prurigo nodularis (PN), chronic spontaneous urticaria (CSU) and bullous pemphigoid (BP).

September 25th marks this year’s observance and celebration of World Lung Day!

This infographic provides an overview of clinical remission in asthma, including its evolving definitions, key remission criteria, supporting evidence, and its importance as a treatment goal in asthma management.
This infographic provides an overview of clinical remission in asthma, including its evolving definitions, key remission criteria, supporting evidence, and its importance as a treatment goal in asthma management.

In this video soundbite from the EAACI 2025 symposium, Dr. Brian Lipworth discusses that co-existing type 2 inflammatory diseases are common in patients with CRSwNP & increasing severity of asthma is associated with higher severity of CRS and prevalence of nasal polyps. Additionally, he explains that patient burden is substantially greater when asthma and CRSwNP are co-existing.